Mayne Pharma | 销售和管理费用



Selling And Administration Expenses 更改 日
Ansell USD 104.45M 115.95M 2024-06
Avita Medical AUD 21.23M 2.57M 2024-12
Cochlear AUD 465.6M 33.6M 2024-06
CSL USD 1.38B 341M 2024-06
Ecofibre AUD 8.03M 1.38M 2024-06
Healius AUD 393.4M 378.35M 2024-12
Integral Diagnostics AUD 169.98M 18.73M 2024-06
Medical Developments International AUD 7.07M 15.4M 2024-06
Nanosonics AUD 24.09M 20.53M 2024-06
Next Science USD 11.91M 2.13M 2024-06
Polynovo AUD 21.13M 18.27M 2024-06
Ramsay Health Care AUD 5.29B 3.2M 2024-12
ResMed USD 241.61M 2.63M 2024-12
Sigma Healthcare AUD 140.17M 5.4M 2024-07
Sonic Healthcare AUD 2.52B 2.46B 2024-12
Telix Pharmaceuticals AUD 87.69M 29.72M 2024-06



Mayne Pharma 销售和管理费用 - 当前值，历史数据，预测，统计，图表和经济日历 - Mar 2025.